Proteomics News and Research RSS Feed - Proteomics News and Research

The term 'proteome' was first coined in 1994, and refers to all the proteins in a cell, tissue, or organism. Proteomics refers to the study of the proteome. Because proteins are involved in almost all biological activities, the proteome is a rich source of biological information.
Joslin study could lead to improved anti-aging drugs

Joslin study could lead to improved anti-aging drugs

In a study published today by Nature, researchers at Joslin Diabetes Center used a microscopic worm (C. elegans) to identify a new path that could lead to drugs to slow aging and the chronic diseases that often accompany it--and might even lead to better cosmetics. [More]
Ceres to develop new method for detecting the presence of Ebola virus in saliva

Ceres to develop new method for detecting the presence of Ebola virus in saliva

Ceres Nanosciences Inc. today announced the commencement of a development program, funded by the Gates Foundation, to use Ceres' Nanotrap particle technology to develop a new method of detecting the presence of the Ebola virus in saliva. [More]
Researchers investigate role of mitochondria in expansion, survival of cancer stem cells

Researchers investigate role of mitochondria in expansion, survival of cancer stem cells

Cancer stem cells are particularly difficult to eradicate and are at the heart of why it is so hard to more effectively treat cancer patients, as the post-treatment survival of cancer stem cells drives tumour recurrence, the systemic spread of cancer and, ultimately, treatment failure. [More]
New microbial analysis has implications for protecting environment, energy recovery and human health

New microbial analysis has implications for protecting environment, energy recovery and human health

An international team of scientists from the Translational Genomics Research Institute and The Luxembourg Centre for Systems Biomedicine have completed a first-of-its-kind microbial analysis of a biological wastewater treatment plant that has broad implications for protecting the environment, energy recovery and human health. [More]
UCLA creates largest-ever protein that self-assembles into molecular 'cage'

UCLA creates largest-ever protein that self-assembles into molecular 'cage'

UCLA biochemists have created the largest-ever protein that self-assembles into a molecular "cage." The research could lead to synthetic vaccines that protect people from the flu, HIV and other diseases. [More]
New method could make Ebola surveillance quicker, cheaper for West African nations

New method could make Ebola surveillance quicker, cheaper for West African nations

A new method for examining the Ebola virus genome could make surveillance quicker and cheaper for West African nations, and help detect new forms of the virus. The detailed procedure is being shared with the research community along with the study paper, which is freely available in the open access journal Genome Biology. [More]
New E-capper from Porvair Sciences

New E-capper from Porvair Sciences

The new E-capper from Porvair Sciences produces top quality seals and minimises the risk of repetitive strain injuries (RSI) in operators tasked with sealing deep well microplates or storage tube racks with re-useable cap mats. [More]
Beckman Coulter Life Sciences contributes its flow cytometry expertise to support the ONE Study

Beckman Coulter Life Sciences contributes its flow cytometry expertise to support the ONE Study

Beckman Coulter Life Sciences is participating in the ONE Study, an international collaboration of scientists across Europe and the USA − and holding its annual general meeting in Regensburg, Germany from 19-21 November 2014. Beckman Coulter is contributing its flow cytometry expertise in cell therapy and diagnostic technologies to support the study’s specific translational research into organ transplantation and immune deficiency diseases such as HIV. [More]
Researchers explain interaction between HNRNPA2B1 protein and pancreatic cancer development

Researchers explain interaction between HNRNPA2B1 protein and pancreatic cancer development

Researchers from the University of Barcelona have described an interaction between the protein HNRNPA2B1 and pancreatic cancer development which remained unknown. The study, published in the journal Gastroenterology, has proved in human cancer cell lines that this protein is essential to the correct activity of the oncogenic protein KRAS, related to cancer start and development. [More]

CytoFLEX flow cytometer from Beckman Coulter Life Sciences delivers full analysis capabilities

Surpassing the performance expectations of full-size, top-line analyzers, the CytoFLEX flow cytometer (www.cytoflexflow.com) from Beckman Coulter Life Sciences delivers high sensitivity and resolution for excellent fluorescence and nanoparticle detection. [More]
Joslin researcher identifies molecular pathway that causes neural tube defects in diabetic pregnancies

Joslin researcher identifies molecular pathway that causes neural tube defects in diabetic pregnancies

Mary R. Loeken, Ph.D., Investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and Associate Professor of Medicine at Harvard Medical School, has discovered a molecular pathway responsible for neural tube defects in diabetic pregnancies. Her latest research findings in this pathway were published in the October issue of Diabetes. [More]
Quadrupole time-of-flight mass spectrometry for life science research analysis announced by Bruker

Quadrupole time-of-flight mass spectrometry for life science research analysis announced by Bruker

Bruker Corporation (NASDAQ: BRKR) announced today, the evolution of their maXis™ line of ultrahigh-resolution quadrupole time-of-flight (UHR-qTOF) mass spectrometers, bringing industry-leading resolution and mass accuracy to the liquid chromatography, time-of-flight MS market space. [More]
InSilico Medicine, CCARL collaborate to improve personalized medicine projects in multiple sclerosis

InSilico Medicine, CCARL collaborate to improve personalized medicine projects in multiple sclerosis

InSilico Medicine, the company focused on drug discovery for cancer and age-related diseases, announced its investment in a research collaboration with Canada Cancer and Aging Research Laboratories, Inc. The companies will collaborate on improving decision making in clinical oncology and discovery, and personalized medicine projects in multiple sclerosis (MS). [More]
YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

YEDA and XL-protein sign deal to commercialize PASylated IFN superagonis

YEDA Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company, have signed a business collaboration agreement to commercialize a PASylated interferon superagonist -- PAS-YNSα8 -- which has been jointly developed by scientists at the Weizmann Institute and XL-protein. [More]
Research initiative focuses on microbial characteristics of Staphylococcus aureus

Research initiative focuses on microbial characteristics of Staphylococcus aureus

Staphylococcus aureus (Sa) and methicillin-resistant staph aureus (MRSA) continue to be among the most common pathogens that overwhelm the immune system, causing serious skin, soft tissue and life-threatening blood-borne infections. [More]
TSRI, STSI researchers receive NIH grants to set up platforms to mine biomedical data

TSRI, STSI researchers receive NIH grants to set up platforms to mine biomedical data

San Diego researchers at The Scripps Research Institute and Scripps Translational Science Institute will receive more than $4.4 million as part of a National Institutes of Health initiative called "Big Data to Knowledge" (BD2K). [More]

Porvair Sciences appoints SPEware Corporation as its exclusive partner

Porvair Sciences, a world leader in applications optimised microplates and microplate equipment has appointed SPEware Corporation (Baldwin Park, CA) as its exclusive partner for supporting and servicing its UltraVap, MiniVap and UltraVap Mistral microplate sample concentration systems. [More]

AB SCIEX announces R&D Director has been awarded the HUPO Science and Technology Award

AB SCIEX, a global leader in life science analytical technologies, announced that Dr. Subhasish “Babu” Purkayastha, Director, R&D at AB SCIEX, has been awarded the Human Proteome Organization (HUPO) Science and Technology Award for efforts in commercialization of isobaric labeling for protein quantification with the development of iTRAQ chemistries. [More]
ERK and JNK enzymes may offer solutions for treating endometrial, colon cancers

ERK and JNK enzymes may offer solutions for treating endometrial, colon cancers

In the quest to solve cancer's mysteries, they come in handy when describing tongue-twisting processes and pathways that somehow allow tumors to form and thrive. Two examples are ERK (extracellular-signal-related kinase) and JNK (c-June N-Terminal Kinase), enzymes that may offer unexpected solutions for treating some endometrial and colon cancers. [More]
Exclusive partnership brings together next-generation proteomics and next-generation sequencing

Exclusive partnership brings together next-generation proteomics and next-generation sequencing

AB SCIEX and Illumina (NASDAQ: ILMN) announced today the OneOmics™ project, an exclusive partnership to bring together SWATH™-based next-generation proteomics (NGP) and next-generation sequencing (NGS) tools in a cloud computing environment. [More]